Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
57.17
+0.48 (0.85%)
Sep 30, 2026, 2:04 PM EDT - Market open
Vaxcyte Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Vaxcyte stock has a consensus rating of "Strong Buy" and an average price target of $109. The average 1-year stock price forecast is 90.66% higher than the current stock price, while the lowest is $67 (+17.19%) and the highest is $163 (+185.11%).
Price Target: $109 (+90.66%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vaxcyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $133 → $130 | Buy | Reiterates | $133 → $130 | +127.39% | Sep 28, 2026 |
| Needham | Needham | Buy Reiterates $110 | Buy | Reiterates | $110 | +92.41% | Sep 25, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $116 | Buy | Reiterates | $116 | +102.90% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $75 | Buy | Maintains | $75 | +31.19% | Aug 6, 2026 |
| BTIG | BTIG | Buy Maintains $89 | Buy | Maintains | $89 | +55.68% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
87.15M
EPS This Year
-8.20
from -5.63
EPS Next Year
-7.22
from -8.20
EPS and Forward PE are based on non-GAAP adjusted numbers.